Drug Trial Radar · NCT00311779
A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis
Last checked: Nov 20, 2026Latest source record: Jul 12, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Mar 2006
Primary completion
Not stated
Study completion Jul 2006
Sponsor
- Lead sponsor
- ParaPRO LLCIndustry
- Sponsor type
- Industry
- First posted
- Apr 6, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Single
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of the study is to determine the safety and efficacy of different strengths of Spinosad topical creme, as compared to a vehicle control, in subjects who have been infested with at least a mild case of Pediculosis capitis (head lice).
Conditions
- Pediculosis Capitis (Head Lice)
Interventions
Spinosad Creme RinseDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy variable: The presence/absence of live lice and/or nits at Day 7 and Day 14.
- Safety Analyses: The assessment of safety will be based on frequency of adverse events and on the scalp evaluations for irritation.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Hill Top Resesarch
Scottsdale, Arizona
Hill Top Research
West Palm Beach, Florida
Hill Top Research
Miamiville, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.